多层基因方法用于识别已批准的药物点
Marie C Sadler1,2,3, Chiara Auwerx1,2,3,4, Patrick Deelen5,6
1University Center for Primary Care and Public Health, Route de Berne 113, 1010 Lausanne, Switzerland.
Cell genomics
|July 26, 2023
概括
使用人类遗传学优先考虑与疾病相关的基因,提高了药物批准的几率. 全基因组关联研究 (GWAS) 显示出强的表现,但网络扩散揭示了当前基因优先级方法中的偏差.
科学领域:
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 针对具有人类遗传证据的基因的药物具有更高的批准率.
- 优先考虑这些基因对于有效的药物发现至关重要.
- 目前的方法包括GWAS,外基因组测序,并将GWAS与eQTL/pQTL数据集成.
研究的目的:
- 为了比较不同基因优先级策略的有效性.
- 在30个临床特征中对这些方法进行基准测试,以确定药物标.
- 评估基因网络扩散对目标识别的影响.
主要方法:
- 基因排序优先级方法的比较:GWAS,Exome,eQTL-GWAS,pQTL-GWAS. 这些都是基因排序优先级的方法.
- 对30个临床相关特征的药物标进行基准测试.
- 基因网络扩散的应用和节点程度的分析.
主要成果:
- 在优先考虑药物目标方面,GWAS表现出最高的赔率比率 (2.17) .
- GWAS的表现优于eQTL-GWAS和pQTL-GWAS,但不是Exome方法.
- 基因网络扩散增强了性能,节点程度是一个强有力的预测因素,但表明了文献偏差.
结论:
- 对药物发现的基因优先级策略的系统评估.
- GWAS是一种强大的方法,尽管外基因组测序也表现良好.
- 网络扩散具有潜力,但由于固有的偏见,需要仔细解释.
关键词:
异源 (exome) 是指外源 (exome) 的一个部分.在GWAS中,GWAS就是GWAS.药物目标发现和发现.我们的eQTL是eQTL.基因优先级的排序网络扩散 网络扩散在pQTLTL中,pQTL是指pQTL.更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.1K
相关概念视频
01:26Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
01:26Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
01:28Structure-Activity Relationships and Drug Design
770
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
770